CTOs on the Move

Crittercism

www.crittercism.com

 
Crittercism, based in San Francisco, California, is the world`s first mobile application performance management (APM) solution. The company`s products monitor every aspect of mobile app performance, allowing Developers and IT Operations to deliver high performing, highly reliable, highly available mobile apps. Crittercism provides a real-time global view of app diagnostics and crashes across iOS, Android, Windows Phone 8, Hybrid and HTML5 apps and is used on more than 500 million unique devices and in more than 50 billion app sessions. The company`s investors include Google Ventures, Opus Capital and Shasta Ventures.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Team Mark

Team Mark is a San Jose, CA-based company in the Software and Internet sector.

Quantum Design Inc

Quantum Design Inc is a Loves Park, IL-based company in the Software and Internet sector.

Latis Technologies

Latis Technologies is a Fairfax, VA-based company in the Software and Internet sector.

ConnectAndSell

ConnectAndSell is a Redwood City, CA-based company in the Software and Internet sector.

IPG

As the Device Benefit Management (DBM) leader, IPG provides transparent end-to-end implant management and predictive analytical solutions, establishing the industry standard around cost, quality and safety to drive accessibility and affordability of care. The company has pioneered a unique DBM model which streamlines the management and delivery of implantable devices by working directly with health plans, clinical providers, facilities and medical device manufacturers. IPG delivers implant intelligence surrounding the overall cost and quality of healthcare being delivered, adding transparency and predictability of spend in tandem with the implementation of quality and safety metrics necessary to drive and reward best practices. Through collaborative partnerships that drive physician alignment, and employer and patient satisfaction, this approach ensures that patients receive increased access to affordable and innovative life-saving and life-enhancing device-intensive medical therapies.